Junqiu W. Xie
Key Laboratory Of Preclinical Study For New Drugs Of Gansu Province, 2019RU066
Lanzhou, 730000, China
Lanzhou, 730000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
All-Hydrocarbon Stapling and Amino Acid Substitution-Modified Antimicrobial Peptide Feleucin-K3 Analogs Enhanced the Stability and Optimized the Therapeutic Index against Multidrug-Resistant Bacteria.
Journal: Journal of medicinal chemistry
Published: June 09, 2026
Postmodification of Daptomycin at Tryptophan Enables the Discovery of Aryl-Daptomycin Antibiofilm Activity against MRSA.
Journal: Journal of medicinal chemistry
Published: May 26, 2026
Cyclization-Based Optimization of the Antimicrobial Peptide YD Yields a Nanomolar Inhibitor of Pulmonary Fibrosis.
Journal: Journal of medicinal chemistry
Published: March 13, 2026
Halogenated Sulfono-γ-AApeptides Modified Cationic AMPs Have Enhanced Stability and Therapeutic Potential against Clinically Important MDR Infections.
Journal: ACS infectious diseases
Published: June 12, 2025
Rational two-round modification for developing isopeptide bond-containing antimicrobial peptide with enhanced stability and potent activity against multidrug-resistant gram-negative bacteria.
Journal: Biochemical pharmacology
Published: June 04, 2025
Iterative Optimization Yields Stapled Peptides with Superior Pharmacokinetics and Potency for Renal Fibrosis Treatment.
Journal: Journal of medicinal chemistry
Published: April 08, 2025
Naturally inspired chimeric quinolone derivatives to reverse bacterial drug resistance.
Journal: European journal of medicinal chemistry
Published: February 06, 2025
Enhancing the stability and therapeutic potential of the antimicrobial peptide Feleucin-K3 against Multidrug-Resistant a. Baumannii through rational utilization of a D-amino acid substitution strategy.
Journal: Biochemical pharmacology
Published: January 24, 2024
Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis.
Journal: ACS pharmacology & translational science
Published: January 11, 2024
Orthogonal bioconjugation targeting cysteine-containing peptides and proteins using alkyl thianthrenium salts.
Journal: Nature communications
Published: December 08, 2023
Last Updated: 09/26/2026